Ullrich Schwertschlag

2.5k total citations · 1 hit paper
50 papers, 1.9k citations indexed

About

Ullrich Schwertschlag is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ullrich Schwertschlag has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ullrich Schwertschlag's work include Gastrointestinal motility and disorders (5 papers), Immune Cell Function and Interaction (5 papers) and Renin-Angiotensin System Studies (5 papers). Ullrich Schwertschlag is often cited by papers focused on Gastrointestinal motility and disorders (5 papers), Immune Cell Function and Interaction (5 papers) and Renin-Angiotensin System Studies (5 papers). Ullrich Schwertschlag collaborates with scholars based in United States, Germany and Canada. Ullrich Schwertschlag's co-authors include E. Hackenthal, Ronald L. Hornung, Martha Quezado, Lloyd Mayer, Peter Mannon, Markus F. Neurath, Jochen Salfeld, Geertruida M. Veldman, William J. Sandborn and Catherine Groden and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ullrich Schwertschlag

50 papers receiving 1.9k citations

Hit Papers

Anti–Interleukin-12 Antibody for Active Crohn's Disease 2004 2026 2011 2018 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Anti–Interleukin-12 Antibody for Active Crohn's Disease
    2004 628 citations Ullrich Schwertschlag et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ullrich Schwertschlag United States 18 811 501 323 321 315 50 1.9k
I. R. Mackay Australia 32 869 1.1× 438 0.9× 456 1.4× 533 1.7× 358 1.1× 88 2.9k
Andrea Finocchi Italy 24 886 1.1× 286 0.6× 505 1.6× 330 1.0× 123 0.4× 84 1.8k
M. Hart Netherlands 30 1.3k 1.6× 252 0.5× 518 1.6× 290 0.9× 400 1.3× 44 2.7k
Jeng‐Hsien Yen Taiwan 29 1.3k 1.7× 223 0.4× 556 1.7× 234 0.7× 368 1.2× 132 2.7k
Jan Heidemann Germany 29 763 0.9× 415 0.8× 751 2.3× 448 1.4× 410 1.3× 65 2.5k
M. Tarek Elghetany United States 22 448 0.6× 290 0.6× 382 1.2× 196 0.6× 253 0.8× 73 1.7k
Dwaipayan Bharadwaj India 24 454 0.6× 460 0.9× 658 2.0× 513 1.6× 117 0.4× 70 2.0k
D.C. Harnish United States 6 633 0.8× 146 0.3× 406 1.3× 236 0.7× 432 1.4× 7 1.6k
Angela Cox United Kingdom 32 560 0.7× 661 1.3× 1.1k 3.3× 239 0.7× 490 1.6× 79 2.9k
Kuo-Jang Kao United States 31 679 0.8× 466 0.9× 707 2.2× 152 0.5× 313 1.0× 84 3.1k

Countries citing papers authored by Ullrich Schwertschlag

Since Specialization
Citations

This map shows the geographic impact of Ullrich Schwertschlag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ullrich Schwertschlag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ullrich Schwertschlag more than expected).

Fields of papers citing papers by Ullrich Schwertschlag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ullrich Schwertschlag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ullrich Schwertschlag. The network helps show where Ullrich Schwertschlag may publish in the future.

Co-authorship network of co-authors of Ullrich Schwertschlag

This figure shows the co-authorship network connecting the top 25 collaborators of Ullrich Schwertschlag. A scholar is included among the top collaborators of Ullrich Schwertschlag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ullrich Schwertschlag. Ullrich Schwertschlag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yue, Edward Gane, Leen Slaets, et al.. (2023). Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants. Antiviral Therapy. 28(1). 211877386–211877386. 2 indexed citations
2.
Mason, Jay W., et al.. (2014). Electrocardiographic and cardiovascular diagnostic characteristics of patients receiving long-term opioid therapy for pain. Journal of Opioid Management. 10(2). 103–109. 4 indexed citations
3.
4.
5.
Papisov, Mikhail, Alan J. Fischman, Alex Hiller, et al.. (2007). MER-1001, a novel polymeric prodrug of camptothecin, is a potent inhibitor of LS174 and A2780 human tumor xenografts in a mouse model. Cancer Research. 67. 781–781. 6 indexed citations
6.
Sausville, Edward A., Stephen P. Anthony, Lawrence Garbo, et al.. (2007). A phase I study of the safety, tolerability, and pharmacokinetics of intravenous XMT-1001 in patients with advanced solid tumors.. 6. 3 indexed citations
7.
Cotreau, Monette, Kevin Dykstra, Judy Oestreicher, et al.. (2005). A Single Administration of Recombinant Human Interleukin‐12 Is Associated With Increased Expression Levels of Interferon‐gamma and Signal Transducer and Activator of Transcription in Healthy Subjects. The Journal of Clinical Pharmacology. 45(6). 649–658. 5 indexed citations
8.
9.
Cotreau, Monette, Sarah Warren, John L. Ryan, et al.. (2003). The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans. The Journal of Clinical Pharmacology. 43(10). 1108–1115. 106 indexed citations
10.
Cotreau, Monette, et al.. (2002). Multiple‐Dose, Safety, Pharmacokinetics, and Pharmacodynamics of a New Selective Estrogen Receptor Modulator, ERA‐923, in Healthy Postmenopausal Women. The Journal of Clinical Pharmacology. 42(2). 157–165. 17 indexed citations
11.
Moreland, Larry W., Kevin R. King, Michael Weisman, et al.. (2001). Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis. Arthritis Research & Therapy. 3(4). 247–52. 41 indexed citations
12.
Oestreicher, Judy, Ian Walters, Toyoko Kikuchi, et al.. (2001). Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. The Pharmacogenomics Journal. 1(4). 272–287. 148 indexed citations
13.
Berl, T. & Ullrich Schwertschlag. (2000). Preclinical pharmacologic basis for clinical use of rhIL-11 as an effective platelet-support agent.. PubMed. 14(9 Suppl 8). 12–20. 6 indexed citations
14.
Sands, Bruce E., Charles A. Sninsky, Seymour Katz, et al.. (1999). Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology. 117(1). 58–64. 146 indexed citations
15.
Reed, Shelby D., Thomas Ryan, Benito J. Cerimele, et al.. (1995). The renin angiotensin aldosterone system and frusemide response in congestive heart failure.. British Journal of Clinical Pharmacology. 39(1). 51–57. 6 indexed citations
16.
Schwertschlag, Ullrich, Benito J. Cerimele, J. L. McNay, Ronald R. Bowsher, & Howard Rowe. (1993). Effect of Tibenelast (a Phosphodiesterase Inhibitor) and Theophylline on Isoproterenol-Stimulated Heart Rate, Cyclic AMP and Norepinephrine Levels. Pharmacology. 46(3). 142–147. 3 indexed citations
17.
Schwertschlag, Ullrich, H. R. Scherf, J G Gerber, Melvin M. Mathias, & Alan S. Nies. (1987). L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney.. Circulation Research. 60(4). 534–539. 22 indexed citations
18.
Schwertschlag, Ullrich, et al.. (1986). Increased PGE2 excretion by dDAVP in humans depends on state of hydration. American Journal of Physiology-Renal Physiology. 250(6). F1008–F1012. 3 indexed citations
19.
Schwertschlag, Ullrich, et al.. (1986). A dual effect of nonsteroidal anti-inflammatory drugs on renal water handling in humans.. Journal of Pharmacology and Experimental Therapeutics. 238(2). 653–658. 5 indexed citations
20.
Schwertschlag, Ullrich, et al.. (1978). The Effects of Calcium and Calcium-Ionophores (X 537 a and a 23187) on Renin Release in the Isolated Perfused Rat Kidney. Clinical Science. 55(s4). 163s–166s. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. R. Mackay Breakdown of academic impact, for papers by Andrea Finocchi Breakdown of academic impact, for papers by M. Hart Breakdown of academic impact, for papers by Jeng‐Hsien Yen Breakdown of academic impact, for papers by Jan Heidemann Breakdown of academic impact, for papers by M. Tarek Elghetany Breakdown of academic impact, for papers by Dwaipayan Bharadwaj Breakdown of academic impact, for papers by D.C. Harnish Breakdown of academic impact, for papers by Angela Cox Breakdown of academic impact, for papers by Kuo-Jang Kao
Rankless by CCL
2026